Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOCUS fluconazole pharmacokinetics study in children and adolescents
NL-OMON59791Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluconazole in invasive mycoses (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Population pharmacokinetics of fluconazole. Started Dec 2024; status: completed.
02
Drugs
fluconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on NL-OMON59791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59791.